Contents

Search

NSS-2 Bridge device

Indications: - opioid withdrawal (use for up to 5 days) * device approved June 2018 [2] Procedure: - small electrical nerve stimulator placed behind the patient's ear - contains a battery-powered chip that emits electrical pulses to stimulate branches of certain cranial nerves - electrical pulses flow to ear-fitted needles from an auricular neurostimulator - device wearable up to 5 days [2]

General

device (medical device) transcutaneous electrical nerve stimulation (TENS, Stimpod NMS460)

References

  1. FDA News Release. Nov 15, 2017 FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm585271.htm
  2. Brauser D FDA Okays Wearable Device for Opioid Withdrawal. Medscape - Jun 13, 2018. https://www.medscape.com/viewarticle/898043